One Patient Changed This Oncologist’s View of Hope. Here’s How.June 19, 2024Patient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
ChatGPT Enhances Readability of Cancer Information for PatientsJune 18, 2024Patient & Survivor CarePractice Management
FDA Expands Durvalumab Label to Endometrial CancerJune 18, 2024Gynecologic CancerPatient & Survivor Care
Surviving to Thriving: Enhancing Quality of Life in Breast CancerJune 17, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
FDA Expands Repotrectinib Label to All NTRK Gene Fusion+ Solid TumorsJune 14, 2024Patient & Survivor CareLung CancerPractice ManagementCNS/Brain CancerBreast CancerGastrointestinal CancerGenitourinary Cancer
Engineering Mind Helps Investigator Develop New Cancer TherapiesJune 13, 2024Gastrointestinal CancerGastroenterologyPatient & Survivor Care
Ovarian Cancer Risk Doubled by Estrogen-Only HRTJune 12, 2024Gynecologic CancerPatient & Survivor CarePreventive CareBreast Cancer
Chemo May Benefit Some Older Patients With Metastatic Pancreatic CancerJune 11, 2024Gastrointestinal CancerPatient & Survivor CareGastroenterology
HPV Vaccine Offers Cancer Protection Beyond Cervical CancerJune 11, 2024Gynecologic CancerGenitourinary CancerPreventive CarePatient & Survivor CareHead & Neck/Thyroid Cancers
Are Children Born Through ART at Higher Risk for Cancer?June 10, 2024Preventive CarePediatricsBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
About 20% of Breast Cancer Survivors Gain Excess WeightJune 10, 2024Breast CancerPatient & Survivor Care
T-DXd Moves Toward First Line for HER2-Low Metastatic BCJune 10, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
Anti-Müllerian Hormone Predicts Chemo Benefits in BCJune 6, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Should ER-Low Breast Cancer Patients Be Offered Endocrine Therapy?June 5, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Neoadjuvant Checkpoint Inhibition Study Sets New Standard of Care in MelanomaJune 4, 2024MelanomaPatient & Survivor Care
